Welcome To DailyEducation

DailyEducation is an open-source platform for educational updates and sharing knowledge with the World of Everyday students.

Cadila Pharma’s rabies vaccine ‘ThRabis’ receives award at Golden Globe Tigers Awards

hanuman

Active member
Award.jpg


Cadila Pharmaceuticals’ three-dose rabies vaccine, Thrabis, has received the ‘Innovative Product of the Year Award’ at The Golden Globe Tigers Awards. Pankaj Sharma, Vertical Head of Cadila Pharmaceuticals’ Magfam Division, accepted the award virtually on behalf of the company.


It is an honour to receive this prestigious Innovative Product of the Year award. We are thankful to The Golden Globe Tigers Awards for this opportunity to share and showcase ThRabis, which is truly a breakthrough vaccine with the potential to save thousands of lives in India and globally. This award is a huge recognition of Thrabis’ potential and reflection of Cadila Pharmaceuticals’ commitment to innovation,” Sharma said.


Launched in April last year, ThRabis is a three-dose recombinant nanoparticle-based rabies G protein vaccine. While other rabies vaccines require five injections spread over 28 days to complete the full regimen, Thrabis has a simpler and more convenient three-dose regimen. Reportedly, in just a year, more than one lakh vials of ThRabis have been administered.


The Golden Globe Tigers Awards recognises leaders in marketing, branding, CSR & social innovation, education and academics.

The post appeared first on .
 
Back
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock